BioCentury
ARTICLE | Management Tracks

Delaney takes over as Assembly’s CSO; plus NGM, TCR2, Amunix, Evox, Vor and more

May 29, 2020 1:49 AM UTC

Assembly Biosciences Inc. (NASDAQ:ASMB) said Richard Colonno will retire as CSO, virology, on June 1. He is succeeded by William Delaney, who spent 20 years at Gilead Sciences Inc. (NASDAQ:GILD), most recently serving as executive director of biology.

Liver and metabolic diseases company NGM Biopharmaceuticals Inc. (NASDAQ:NGM) hired Siobhan Nolan Mangini as CFO, effective July 13. She was president and CFO of Castlight Health Inc. (NYSE:CSLT)...